- Home
- Industry Reports
- Healthcare
- Healthcare IT
- Digital Therapeutics Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Digital therapeutics, a part of digital health that utilizes digital tools such as software’s or devices to monitor treatment schedules and also treat medical conditions of an individual. This platform builds a bridge between patients, payers and physicians thus helping in the monitoring of treatment. Global digital therapeutic devices market was valued at approximately $170 Million in 2017 and is expected to generate revenue of around $520 Million by the end of 2024, growing at a CAGR of around 27.9% between 2017 and 2024. Rising focus on preventive healthcare and a significant increase in venture capital investments are the factors enhancing the growth of the market. Patient data privacy concerns and unfavourable payment models are the factors which hamper the market growth. Unexplored therapeutic applications and emerging markets which offer significant growth are the opportunities for digital therapeutics market.
Research Study Objectives:
- Define, estimate, and forecast the Digital Therapeutics market statistics by sales channel, type of application, and regions concerning the individual growth drivers, market trends and their contribution toward the Digital Therapeutics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Digital Therapeutics Market Analysis
- Analysis and conclusions on the future Digital Therapeutics market outlook.
Top-down and bottom-up approaches are used to validate the Digital Therapeutics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Digital Therapeutics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Digital Therapeutics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Digital Therapeutics market segmentation is as follows:
By Sales Channel
- B2C
- B2B
By Type of Application
- Preventive applications
- Treatment/Care-related applications
Geographical Analysis:
Digital Therapeutics Market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Digital Therapeutics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Digital Therapeutics Market Research Report Includes:
- An executive summarycondensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Digital Therapeutics market players, such as
- Canary Health, Inc.
- IBM Corporation
- Mango Health, Inc.
- Reciprocal Labs Corporation.
- Proteus Digital Health.
- Along with these companies, many other companies are considered in the report while analysing the Global Digital Therapeutics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising focus on preventive healthcare
4.1.2. Need to control healthcare costs
4.1.3. A significant increase in venture capital investments
4.1.4. Increasing incidence of preventable chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Patient data privacy concerns
4.2.2. Unfavourable payment models
4.3. Market Opportunities
4.3.1. Unexplored therapeutic applications
4.3.2. Emerging markets offer significant growth opportunities
CHAPTER 5 GLOBAL DIGITAL THERAPEUTICS MARKET – BY SALES CHANNEL
5.1. Introduction
5.2. B2C
5.2.1. Caregivers
5.2.2. Patients
5.3. B2B
5.3.1. Providers
5.3.2. Payers
5.3.3. Pharmaceutical Companies
5.3.4. Employers
5.3.5. Other Buyers
CHAPTER 6 GLOBAL DIGITAL THERAPEUTICS MARKET – BY TYPE OF APPLICATION
6.1. Introduction
6.2. Preventive applications
6.2.1. Prediabetes
6.2.2. Obesity
6.3. Treatment/Care-related applications
6.3.1. Diabetes
6.3.2. Central nervous system (CNS) Disorders
6.3.3. Chronic respiratory diseases (CRD)
6.3.4. Musculoskeletal disorders
6.3.5. Cardiovascular diseases
6.3.6. Smoking cessation
6.3.7. Medication adherence
6.3.7. Other applications
CHAPTER 7 GLOBAL DIGITAL THERAPEUTICS MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8 GLOBAL DIGITAL THERAPEUTICS MARKET – COMPANY PROFILES
8.1. Canary Health, Inc.
8.2. IBM Corporation
8.3. Evolent Health, Inc.
8.4. Livongo Health, Inc.
8.5. Mango Health, Inc.
8.6. Nanobiosym, Inc.
8.7. Noom Health, Inc.
8.8. Omada Health, Inc.
8.9. Pear Therapeutics, Inc.
8.10. Perfint Healthcare Pvt. Ltd.
8.11. Reciprocal Labs Corporation.
8.12. Proteus Digital Health.
8.13. Twine Health, Inc.
8.14. Well Doc Inc.
8.15. Zest Health, LLC.
CHAPTER 9 GLOBAL DIGITAL THERAPEUTICS MARKET – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10 MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11 APPENDIX
11.1. List of Tables
11.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,506.73 - €7,520.19
- INR: ₹225,089.41 - ₹675,268.22
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,149.52 - £6,448.57
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Digital therapeutics, a part of digital health that utilizes digital tools such as software’s or devices to monitor treatment schedules and also treat medical conditions of an individual. This platform builds a bridge between patients, payers and physicians thus helping in the monitoring of treatment. Global digital therapeutic devices market was valued at approximately $170 Million in 2017 and is expected to generate revenue of around $520 Million by the end of 2024, growing at a CAGR of around 27.9% between 2017 and 2024. Rising focus on preventive healthcare and a significant increase in venture capital investments are the factors enhancing the growth of the market. Patient data privacy concerns and unfavourable payment models are the factors which hamper the market growth. Unexplored therapeutic applications and emerging markets which offer significant growth are the opportunities for digital therapeutics market.
Research Study Objectives:
- Define, estimate, and forecast the Digital Therapeutics market statistics by sales channel, type of application, and regions concerning the individual growth drivers, market trends and their contribution toward the Digital Therapeutics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Digital Therapeutics Market Analysis
- Analysis and conclusions on the future Digital Therapeutics market outlook.
Top-down and bottom-up approaches are used to validate the Digital Therapeutics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Digital Therapeutics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Digital Therapeutics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Digital Therapeutics market segmentation is as follows:
By Sales Channel
- B2C
- B2B
By Type of Application
- Preventive applications
- Treatment/Care-related applications
Geographical Analysis:
Digital Therapeutics Market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Digital Therapeutics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Digital Therapeutics Market Research Report Includes:
- An executive summarycondensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Digital Therapeutics market players, such as
- Canary Health, Inc.
- IBM Corporation
- Mango Health, Inc.
- Reciprocal Labs Corporation.
- Proteus Digital Health.
- Along with these companies, many other companies are considered in the report while analysing the Global Digital Therapeutics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising focus on preventive healthcare
4.1.2. Need to control healthcare costs
4.1.3. A significant increase in venture capital investments
4.1.4. Increasing incidence of preventable chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Patient data privacy concerns
4.2.2. Unfavourable payment models
4.3. Market Opportunities
4.3.1. Unexplored therapeutic applications
4.3.2. Emerging markets offer significant growth opportunities
CHAPTER 5 GLOBAL DIGITAL THERAPEUTICS MARKET – BY SALES CHANNEL
5.1. Introduction
5.2. B2C
5.2.1. Caregivers
5.2.2. Patients
5.3. B2B
5.3.1. Providers
5.3.2. Payers
5.3.3. Pharmaceutical Companies
5.3.4. Employers
5.3.5. Other Buyers
CHAPTER 6 GLOBAL DIGITAL THERAPEUTICS MARKET – BY TYPE OF APPLICATION
6.1. Introduction
6.2. Preventive applications
6.2.1. Prediabetes
6.2.2. Obesity
6.3. Treatment/Care-related applications
6.3.1. Diabetes
6.3.2. Central nervous system (CNS) Disorders
6.3.3. Chronic respiratory diseases (CRD)
6.3.4. Musculoskeletal disorders
6.3.5. Cardiovascular diseases
6.3.6. Smoking cessation
6.3.7. Medication adherence
6.3.7. Other applications
CHAPTER 7 GLOBAL DIGITAL THERAPEUTICS MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8 GLOBAL DIGITAL THERAPEUTICS MARKET – COMPANY PROFILES
8.1. Canary Health, Inc.
8.2. IBM Corporation
8.3. Evolent Health, Inc.
8.4. Livongo Health, Inc.
8.5. Mango Health, Inc.
8.6. Nanobiosym, Inc.
8.7. Noom Health, Inc.
8.8. Omada Health, Inc.
8.9. Pear Therapeutics, Inc.
8.10. Perfint Healthcare Pvt. Ltd.
8.11. Reciprocal Labs Corporation.
8.12. Proteus Digital Health.
8.13. Twine Health, Inc.
8.14. Well Doc Inc.
8.15. Zest Health, LLC.
CHAPTER 9 GLOBAL DIGITAL THERAPEUTICS MARKET – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10 MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11 APPENDIX
11.1. List of Tables
11.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.